Compound Detail
CHEMBL1236524
GALIDESIVIR 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL1236524 |
| Name | GALIDESIVIR |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | AMFDITJFBUXZQN-KUBHLMPHSA-N |
| Active Moiety | CHEMBL4594369 |
16
Targets
33
Activities
2
Assay Types
2
PK Parameters
20
Publications
4
Known Names
3
Indications
5
Mechanisms
Molecular Properties
265.3
MW (Da)
-1.73
ALogP
7
HBA
6
HBD
140.3
PSA (Ų)
0.38
QED
1
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| RNA-directed RNA polymerase L inhibitor | INHIBITOR | RNA-directed RNA polymerase L | ✓ | ✓ |
| Genome polyprotein inhibitor | INHIBITOR | Genome polyprotein | ✓ | ✓ |
| Genome polyprotein inhibitor | INHIBITOR | Genome polyprotein | ✓ | ✓ |
| RNA-directed RNA polymerase L inhibitor | INHIBITOR | RNA-directed RNA polymerase L | ✓ | ✓ |
| Replicase polyprotein 1ab inhibitor | INHIBITOR | Replicase polyprotein 1ab | ✓ | ✓ |
Indications
Fever Marburg Virus Disease Severe Acute Respiratory Syndrome
Activity Summary
EC50 31 meas. best 6.0
Ki 2 meas. best 7.48
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Purine nucleoside phosphorylase CHEMBL4338 | Ki | 7.48 | 7.48 | 33.0 | 1 |
| Influenza B virus CHEMBL613129 | EC50 | 6.0 | 6.0 | 1000.0 | 1 |
| Influenza A virus CHEMBL613740 | EC50 | 6.0 | 5.64 | 1000.0 | 3 |
| Measles morbillivirus CHEMBL613738 | EC50 | 5.75 | 5.75 | 1800.0 | 1 |
| Purine nucleoside phosphorylase CHEMBL2935 | Ki | 5.58 | 5.58 | 2600.0 | 1 |
| Marburgvirus CHEMBL4296577 | EC50 | 5.52 | 5.44 | 3000.0 | 2 |
| Ebolavirus CHEMBL4434621 | EC50 | 5.52 | 5.1267 | 3000.0 | 3 |
| Sudan ebolavirus CHEMBL5291667 | EC50 | 5.52 | 5.52 | 3000.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 5.47 | 5.47 | 3400.0 | 1 |
| dengue virus type 2 CHEMBL613966 | EC50 | 5.38 | 4.874 | 4200.0 | 5 |
| Zika virus CHEMBL4296612 | EC50 | 4.92 | 4.7 | 12000.0 | 2 |
| SARS-CoV-2 CHEMBL4303835 | EC50 | 4.85 | 4.4433 | 14150.0 | 3 |
| Yellow fever virus CHEMBL613731 | EC50 | 4.75 | 4.75 | 18000.0 | 1 |
| Rift Valley fever virus CHEMBL613130 | EC50 | 4.64 | 4.605 | 23000.0 | 2 |
| Middle East respiratory syndrome-related coronavirus CHEMBL4296578 | EC50 | 4.5 | 4.29 | 32000.0 | 5 |
| SARS-CoV CHEMBL4303836 | EC50 | 4.24 | 4.24 | 57700.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| T1/2 | 0.08333 | hr | Mus musculus |
| T1/2 | 6.2 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine